MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Laboratory Corporation of America Holdings Depreciation & Amortization 2011-2026 | LH
Annual Depreciation & Amortization Laboratory Corporation of America Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 681 M | 644 M | 577 M | 537 M | 577 M | 625 M | 577 M | 552 M | 533 M | 499 M | 458 M | 246 M | 230 M | 230 M | 231 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 681 M | 230 M | 480 M |
Quarterly Depreciation & Amortization Laboratory Corporation of America Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.5 M | 68.3 M | 167 M | - | 63.7 M | 62.2 M | 154 M | - | 55.7 M | 51.5 M | 142 M | - | 49 M | 49.8 M | 162 M | - | 557 M | 92.4 M | 184 M | - | 441 M | 288 M | 145 M | - | 421 M | 277 M | 136 M | - | 414 M | 281 M | 143 M | - | 388 M | 255 M | 128 M | - | 369 M | 248 M | 122 M | - | 340 M | 220 M | 103 M | - | 182 M | 124 M | 246 M | - | 170 M | 112 M | 55.5 M | - | 170 M | 113 M | 56.7 M | - | 174 M | 116 M | 58.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 557 M | 49 M | 183 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
167 K | $ 92.59 | 5.9 % | $ 4.33 B | USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 4.5 | -10.89 % | $ 5.99 M | USA |
 |
Fulgent Genetics
FLGT
|
24.1 M | $ 18.5 | 1.04 % | $ 569 M | USA |
 |
Castle Biosciences
CSTL
|
40.8 M | $ 21.08 | 4.77 % | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.4 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
383 M | $ 151.82 | -0.28 % | $ 11.9 B |  Irlanda |
 |
Illumina
ILMN
|
270 M | $ 160.03 | 1.26 % | $ 24.8 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 130.12 | 4.19 % | $ 16.3 B | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 22.75 | 3.64 % | $ 1.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.74 | 3.57 % | $ 7.7 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
NeoGenomics
NEO
|
36.1 M | $ 11.44 | 4.47 % | $ 1.47 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 19.75 | 2.17 % | $ 442 M | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 99.98 | -0.03 % | $ 6.75 B | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 189.85 | 1.83 % | $ 9.41 B | USA |
 |
Pacific Biosciences of California
PACB
|
13 M | $ 1.37 | -0.72 % | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 466.79 | 1.94 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 162.79 | 2.1 % | $ 24 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.54 | 3.42 % | $ 420 M | USA |
 |
Natera
NTRA
|
41.8 M | $ 222.82 | 4.38 % | $ 30.5 B | USA |
 |
Personalis
PSNL
|
10 M | $ 9.75 | -2.89 % | $ 870 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 26.5 | 2.63 % | $ 25.1 B |  Niderland |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 7.43 | 4.21 % | $ 310 M | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.02 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.05 | -0.92 % | $ 4.71 M | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 70.06 | 0.03 % | $ 4.19 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 494.07 | 5.23 % | $ 186 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.29 | 2.43 % | $ 2.01 B | USA |
 |
Waters Corporation
WAT
|
88.1 M | $ 371.15 | 2.15 % | $ 22.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 204.53 | 3.71 % | $ 22.7 B | USA |